A doctor on TikTok weighs in on the celebrity weight loss wave, tagging Ozempic and Ariana Grande in his explanation.
Recap by typeshit. Video by @doctoryoun on TikTok.
Kalkine Media ties the attention on Lilly to orforglipron's progress, arguing a pill could scale cheaper than injectables and ease supply limits.
Smaller portions could become more common on shelves, with inflation and GLP-1 appetite changes both pushing food makers toward personal packs.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
Oral Wegovy brought in about $850 million in H1 2026 and holds over 80% of new US oral scripts. Lilly says Foundayo volume doubled in a month.
Food brands are marketing products to people on GLP-1 drugs, and nutritionists say the label alone tells you little about what's actually in them.
Weintraub shares a link comparing the online trade in unapproved peptides to bootlegging. The post itself carries no further detail.
Loading…